Royce & Associates Goes Back To School With Scholastic

According to a 13G filed with the SEC, as of October 31st Royce & Associates, a fund managed by Chuck Royce which tends to invest in smaller-cap value stocks (see stocks that Royce & Associates owned at the end of June), owned 3.1 million shares of Scholastic Corp (NASDAQ:SCHL). This gives the fund ownership of just over 10% of the outstanding shares, and represents an increase from the end of June when Royce & Associates reported a position of 2.6 million shares in its 13F filing. Scholastic is a $1.1 billion market cap publishing and media company focused on providing educational content for children.

Chuck Royce

In the first quarter of Scholastic Corp’s fiscal year (the quarter ending in August), the company reported an 8% decline in revenue compared to the same period in the last fiscal year. Expenses were down but Scholastic still ended up with a somewhat larger net loss than a year earlier- losses per share were $1.02 versus 87 cents. Scholastic’s business is quite seasonal, picking up in the fall and spring, and so this poorer performance shouldn’t be overemphasized by investors.

The company’s pricing, however, suggests that the market is a bit pessimistic about Scholastic’s future prospects. The trailing P/E is only 11, with the forward P/E rising to 12 as analysts expect lower earnings per share in the fiscal year ending in May 2014 than what the company has been turning in recently. It’s easy to see why Royce likes the stock: those multiples place Scholastic Corp in value territory, and it has a small enough market capitalization that larger funds might ignore it. Our data suggests that the next largest hedge fund position in the stock at the end of the second quarter was the 340,000 shares owned by Renaissance Technologies, founded by billionaire Jim Simons; Cliff Asness’s AQR Capital Management had a slightly smaller position. Find more stocks from Renaissance Technologies and from AQR Capital Management. We’re worried about the fact that the sell-side is being so negative (as well as the fact that 16% of the shares outstanding are held short), and with the lower earnings last quarter we’d like to wait for the crucial results from the fiscal quarter ending in November to come in.

Scholastic’s peers include publishers The McGraw-Hill Companies, Inc. (NYSE:MHP), Pearson PLC (NYSE:PSO), and John Wiley & Sons Inc (NYSE:JW.A). These companies’ forward P/E multiples are in the 12-14 range, so Scholastic is at the lower end of this peer group in that regard. McGraw-Hill and Pearson are significantly larger in terms of market capitalization, and both of these companies currently operate financial information businesses (McGraw-Hill is in fact planning to spin out its education division) which we think are more attractive businesses. McGraw-Hill also saw its earnings tick up rather than down in its most recent quarter versus a year ago, while Pearson actually has a decline in earnings built into its price given that it is trading at only 11 times trailing earnings. Either of these two companies looks more attractive at first glance, though given that they are in the publishing industry we’d have to look at them very carefully. Wiley- which while smaller than the other two still has over twice Scholastic’s market cap- saw its revenue drop 5% in its most recent quarter compared to the same period in 2011, which combined with lower margins drove earnings down 29%. We’d prefer McGraw-Hill, as that company carries only a small premium but seems to be in a better position business-wise.

Scholastic can also be compared to children’s curriculum developer K12 Inc. (NYSE:LRN). K12 is more of a growth company, with its revenue and earnings rising, but it trades at high earnings multiples as investors are depending on that growth to continue for some time in order to justify its current price. At a market cap of about $740 million, it trades at 30 times expected earnings for the current fiscal year (ending in June 2013). Like Scholastic, K12 is a target for short sellers and we’d avoid it as well.

There’s something to be said for Royce increasing its position in Scholastic, but that fund is outnumbered by short sellers who are willing to invest in the company being overvalued at the current price. We wouldn’t quite recommend a short- the P/E multiple is quite low- but think that investors should stay away from buying as well for now.

Biotech Insider Alert - $6 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The Oldest Money Managers

The Greatest Directors in the World

Largest Animals in the World

World’s Most Expensive Desserts

Best Selling Comic Books of All Time

A-list Actors who Sabotaged Their Career

Rappers With a College Degree

The Best Jazz Albums of all Time

The Most Influential Jazz Musicians

The World’s Most Famous Photographers

The Best Oscar-Winning Songs

Most Influential Choreographers Ever

Most Expensive Department Stores in the World

The Most Expensive Stolen Paintings in the World

The World’s Most Expensive Teas

Top Oscar Record Holders

The Most Expensive Flowers in the World

Countries With a Booming Film Industry

Most Expensive Cupcakes in the World

Uncommon European Escapes

The Most Stolen Artists in History

Best Travel Destinations in Australia

World’s Most Expensive Musical Instruments

World’s Most Famous Animals

Most Expensive Cakes in the World

Most Expensive Kosher Champagne in the World

Most Expensive Kosher Wine in the World

The Most Surprisingly Dark Fairy Tales

Most Popular Travel Destinations in Asia

The 10 Most Expensive Dresses Ever Worn to the Oscars

World’s Most Visited Art Museums

Best Countries for Photographers to Work in

Best Paid Jobs in the Film Industry

The Most Renowned Recovered Paintings Ever

Child Stars That Turned out Just Fine

Books That Were Banned in the Past Century

World’s Richest Dancers

Best Remedies against Bad Breath

Foods That Improve Your Skin Texture

Best-Selling Children’s Books of all Time

Foods That Boost Your Libido

Best-Selling Books of all Time

The Most Expensive Academy Awards Jewelry in History

Most Expensive Japanese Restaurant In New York City

The Best B-Boy Movies

Most Awesome Hip Hop Documentaries

Foods That Stain Your Teeth

Richest Doctors in the World

The Best Movie Sountracks Ever

The Highest Grossing Musicals on Broadway

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!